INDmoney
SMMT
Summit Therapeutics Inc Earnings
$16.12
Earnings Summary
Revenue | $0Mn |
Net Profits | $-219.17Mn |
Net Profit Margins | -Inf% |
Summit Therapeutics Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q4 2025. On a quarterly growth basis, Summit Therapeutics Inc has generated NaN% jump in its revenue since last 3-months.
Summit Therapeutics Inc’s net profit fell -258.11% since last year same period to $-219.17Mn in the Q4 2025. On a quarterly growth basis, Summit Therapeutics Inc has generated 5.44% jump in its net profits since last 3-months.
Summit Therapeutics Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q4 2025. On a quarterly growth basis, Summit Therapeutics Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.12 |
EPS Estimate Current Year | -0.12 |
Summit Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.12 - a -52.13% fall from last quarter’s estimates.
Summit Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.12.
Key Ratios
Earning Per Share (EPS) | 0 |
Summit Therapeutics Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the Summit Therapeutics Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-05-07 | -0.12 | 0 | 100% |
